<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="52" height="12" font="1">June 1, 2011</text>
<text top="359" left="94" width="364" height="12" font="1">Mouse monoclonal IgG raised against human recombinant GATA-3 (amino acids 1-264).</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="24" height="12" font="2">siRNA</text>
<text top="134" left="326" width="66" height="12" font="1">frietze@usc.edu</text>
<text top="134" left="83" width="49" height="12" font="1">Seth Frietze</text>
<text top="215" left="121" width="102" height="12" font="1">GATA-3 (HG3-35): sc-269</text>
<text top="215" left="339" width="29" height="12" font="1">GATA3</text>
<text top="170" left="230" width="37" height="12" font="1">Farnham</text>
<text top="255" left="239" width="108" height="12" font="1">Santa Cruz biotechnology</text>
<text top="485" left="361" width="28" height="12" font="1">Mouse</text>
<text top="300" left="395" width="32" height="12" font="1">A10404</text>
<text top="300" left="215" width="27" height="12" font="1">sc-269</text>
<text top="521" left="395" width="19" height="12" font="2">ChIP</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="50" height="12" font="2">Monoclonal</text>
<text top="413" left="94" width="449" height="12" font="1">This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains </text>
<text top="425" left="94" width="449" height="12" font="1">two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role </text>
<text top="437" left="94" width="429" height="12" font="1">in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural </text>
<text top="449" left="94" width="210" height="12" font="1">deafness and renal dysplasia (provided by RefSeq).</text>
<text top="599" left="238" width="159" height="12" font="1">http://datasheets.scbt.com/sc-269.pdf</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="128" left="125" width="423" height="12" font="1">GATA3 siRNA transfection and western blotting: 20 nM siRNA targeting GATA3 or non-specific control </text>
<text top="140" left="125" width="420" height="12" font="1">siRNA (siCONTROL) were transfected into MCF-7 cells using lipofectamine for 72 hours. 15 ug nuclear </text>
<text top="152" left="125" width="424" height="12" font="1">extracts were loaded for SDS-PAGE and western blotting using anti-GATA3 antibodies (1ug/mL). Actin </text>
<text top="164" left="125" width="393" height="12" font="1">was used as a loading control, the same membrane was stripped and reprobed with anti-Actin </text>
<text top="176" left="125" width="94" height="12" font="1">antibodies (0.1ug/mL).</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="117" left="130" width="419" height="12" font="1">ChIP-seq was performed using a GATA3 antibody in SHSY5Y cells. The top 1000 peaks were analyzed </text>
<text top="129" left="130" width="413" height="12" font="1">with a de novo motif analysis (http://motif.bmi.ohio-state.edu/ChIPMotifs/).  The top motif that was </text>
<text top="141" left="130" width="416" height="12" font="1">identified was TTATCT (P value: 1.965e-319), which in the reverse direction is AGAGAA.  A previously </text>
<text top="153" left="130" width="398" height="12" font="1">identified motif for GATA1 using ChIP-seq data is WGATAR (Mol Cell. 36:667-681, 2009), which is </text>
<text top="165" left="130" width="377" height="12" font="1">essentially the same as the new de novo motif identified for GATA3.  We then analyzed the </text>
<text top="177" left="130" width="423" height="12" font="1">percentage of peaks containing the de novo GATA3 motif in the entire set of GATA3 called peaks.  We </text>
<text top="189" left="130" width="411" height="12" font="1">found that 78% of the top 1000 peaks  contained this motif, with the % dropping to 70% in the top </text>
<text top="201" left="130" width="164" height="12" font="1">5000 and to 60% in the entire dataset.   </text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
